RNS Number : 6617M
Arcontech Group PLC
22 January 2021
 

ARCONTECH GROUP PLC

("Arcontech", the "Company" or the "Group")

Issue of Equity

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, announces that it has applied to the London Stock Exchange for 37,301 ordinary shares of £0.125 each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to an exercise of options over Ordinary Shares by a former employee of the Company.

 

It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 26 January 2021. On Admission the Company's issued share capital will comprise 13,327,811 Ordinary Shares, of which none are held in treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights will be 13,327,811. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Arcontech Group plc

020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director


Matthew Jeffs, Chief Executive




finnCap Ltd (Nomad & Broker)

020 7220 0500

Carl Holmes/Simon Hicks


To access more information on the Group please visit: www.arcontech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFLRLRIFFIL